Genentech Inc. (Manufacturing of unpackaged products, primary packaging)
UkraineAll drugs from this manufacturer
-
The drug is used for the treatment of breast cancer (at various stages) and metastatic gastric cancer or gastroesophageal junction cancer, provided there is HER2 protein overexpression in the tumor.
Dosage form: lyophilisate for concentrate for infusion solution
Active substance Dosage trastuzumab 150 mg ATC: L01FD01